JP Morgan Chase
ASTX

JP Morgan Chase’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

JP Morgan Chase’s Portfolio ASTX Stock Details ASTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-1,378,833
Closed -$11.7M – 4483
2013
Q3 		$11.7M Buy
1,378,833
+1,345,069
+3,984% +$8.51M ﹤0.01% 1670
2013
Q2 		$139K Buy
+33,764
New +$182K ﹤0.01% 4077

JP Morgan Chase's ASTX Position: Q4 2013 in Review

JP Morgan Chase sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 1,378,833 shares — an estimated $11.7M sold.

JP Morgan Chase first reported a position in ASTX in Q2 2013 and held it in 2 quarters. The position peaked at $11.7M in Q3 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

  • JP Morgan Chase reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
  • JP Morgan Chase sold 1,378,833 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $11.7M.
  • JP Morgan Chase first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q2 2013 and held it in 2 quarters.
  • JP Morgan Chase's ASTEX PHARMACEUTICALS, INC COM position peaked at $11.7M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on JP Morgan Chase's 13F filing for Q4 2013, filed 13 Feb 2014.